Skip to main content

Table 1 COVID-19 survey module participant characteristics, by country; n (%)

From: Perspectives on sexual and reproductive health self-care among women, healthcare providers, and other key informants: a mixed-methods study in South Africa and Zambia

 

South Africa (n = 342)

Zambia (n = 195)

Total (n = 537)

p-value

Age at COVID survey (mean, SD)a

27.8 (3.9)

29.6 (4.7)

28.4 (4.2)

< 0.001

 19–24

88 (25.7)

48 (24.6)

136 (25.3)

< 0.001

 25–30

195 (57.0)

73 (37.4)

268 (49.9)

 

 31–39

59 (17.3)

74 (38.0)

133 (24.8)

 

Level of educationb

   

< 0.001

 No schooling

0 (0.0)

13 (6.7)

13 (2.4)

 

 Primary school

0 (0.0)

73 (37.4)

73 (13.6)

 

 Secondary school, not complete

108 (31.6)

77 (39.5)

185 (34.5)

 

 Secondary school, complete

148 (43.3)

25 (12.8)

173 (32.2)

 

 Attended post-secondary school

86 (25.2)

7 (3.6)

93 (17.3)

 

Parity (mean, SD)b

1.2 (0.9)

2.6 (1.3)

1.7 (1.3)

< 0.001

Employment statusc*

   

< 0.001

 Homemaker/Unemployed/Other

183 (53.8)

134 (69.4)

317 (59.5)

 

 Student

61 (17.9)

4 (2.1)

65 (12.2)

 

 Part or full-time employment

96 (28.2)

55 (28.5)

151 (28.3)

 

Partner statusc**

   

 < 0.001

 Living together (married/unmarried)

20 (5.9)

172 (88.7)

192 (36.0)

 

 Not living together (married/unmarried)

303 (89.1)

21 (10.8)

324 (60.7)

 

 No current partner***

17 (5.0)

1 (0.5)

18 (3.4)

 

Method at ECHO exit/CUBE enrollment

   

0.69

 LNG implant (Jadelle)

113 (33.1)

70 (35.9)

183 (34.1)

 

 Copper IUD

89 (26.0)

45 (23.1)

134 (24.9)

 

 3-month injectable

140 (40.9)

80 (41.0)

220 (41.0)

 

Contraceptive method using at COVID survey

   

 < 0.001

 None

34 (9.9)

61 (31.3)

95 (17.7)

 

 LNG implant (Jadelle)

77 (22.5)

47 (24.1)

124 (23.1)

 

 ENG implant (Implanon)

5 (1.5)

3 (1.5)

8 (1.5)

 

 Copper IUD

72 (21.1)

29 (14.9)

101 (18.8)

 

 2-month injectable

3 (0.9)

0 (0.0)

3 (0.6)

 

 3-month injectable

107 (31.3)

46 (23.6)

153 (28.5)

 

 Oral contraceptives

4 (1.2)

6 (3.1)

10 (1.9)

 

 Male/female condoms

39 (11.4)

2 (1.0)

41 (7.6)

 

 Standard Days Method/Cycle Beads

1 (0.3)

1 (0.5)

2 (0.4)

 
  1. aCalculated based on age at ECHO enrollment and date of COVID survey; bCollected at ECHO enrollment; cCollected at CUBE 24 month survey; *2 missing from South Africa and 2 missing from Zambia; **2 missing from South Africa and 1 missing from Zambia; ***Includes widowed/separated/divorced; LNG: levonorgestrel; IUD: intrauterine device; ENG: etonogestrel